Hjem › Brystkræft › Michigan › Lansing
Brystkræft kliniske forsøg i Lansing, MI
10 studier for Brystkræft søger deltagere på steder i og omkring Lansing (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
- University of Michigan Health - Sparrow Lansing, Lansing
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekruttererFase 3
- Karmanos Cancer Institute at McLaren Greater Lansing, Lansing
- University of Michigan Health - Sparrow Lansing, Lansing
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
RekruttererFase 3
- Karmanos Cancer Institute at McLaren Greater Lansing, Lansing
E-Mindfulness Approaches for Living After Breast Cancer
RekruttererFase 3
- University of Michigan Health - Sparrow Lansing, Lansing
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
RekruttererFase 2
- Herbert-Herman Cancer Center, Sparrow Hospital, Lansing
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RekruttererFase 3
- Karmanos Cancer Institute at McLaren Greater Lansing, Lansing
A Study of the TheraBionic P1 Device in Breast Cancer
Rekrutterer
- Karmanos Cancer Institute at McLaren Greater Lansing, Lansing
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservationsstudie
- Massive Bio SYNERGY-AI site, Lansing
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
RekruttererFase 3
- Karmanos Cancer Institute at McLaren Greater Lansing, Lansing
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
RekruttererObservationsstudie
- Sparrow Cancer Center, Lansing
Brystkræft forsøg i andre byer
- New York City, NY134 studier
- Houston, TX126 studier
- Boston, MA111 studier
- Nashville, TN80 studier
- Los Angeles, CA72 studier
- Edison, NJ68 studier
- St. Louis, MO64 studier
- Durham, NC63 studier
- Queens, NY63 studier
- Chicago, IL58 studier
- Philadelphia, PA56 studier
- Dallas, TX55 studier
Andre studier i Lansing
- Lungecancer11 studier
- Prostatakræft10 studier
- Ikke-småcellet lungecancer9 studier
- Kræft (alle typer)6 studier
- Larynxcancer5 studier
- Blærecancer5 studier
- Forstyrrelser med overdreven søvnighed5 studier
- Colorektal kræft4 studier
- Nyrekancer (renocellulært karcinom)4 studier
- Tyktarmskræft4 studier
- Urotelial (overgangscelle) carcinom4 studier
- Pladecellekræft i hoved og hals4 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.